Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Pollen Allergy Market Snapshot (2023 to 2033)

The global pollen allergy market is currently valued at US$ 5850.8 Million in 2023 and is anticipated to expand at a CAGR of 4.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 8828.6 Million by 2033.

“The rising prevalence of allergic disorders and their burden across the globe are likely to drive the growth of the pollen allergy market in the forecast period.”

Report Attribute Details
Expected Market Value (2023) US$ 5850.8 Million
Projected Forecast Value (2033) US$ 8828.6 Million
Global Growth Rate (2023 to 2033) 4.2% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Pollen Allergy Market Revenue Analysis 2018 to 2022 vs. Future Outlook 2023 to 2033

The pollen allergy market is expected to gain market growth in the forecast period of 2023 to 2033. Latest market analysis by FMI the market is to grow at a CAGR of 4.2% in the above-mentioned forecast period.

Pollens are referred to as mostly consist of tiny particles released by grasses, trees, and plants during their reproductive cycle. These pollen particles can easily gasp by animals and humans which can cause inflammation and irritation to some individuals and this allergy can lead to fever and rhinitis.

Patients with pollen allergy need to be aware of the changes that can occur in their area to help them adapt to changes in the pattern and presentation of disease that may result from climate change. The global pollen allergy market rose at a CAGR of 3.8% from 2018 to 2022.

What Market Trends Are Influencing the Pollen Allergy Market?

The rising Prevalence of Allergy and Changing Lifestyle Leading to Decreased Immune Resistance drive the Pollen Allergy Market

The rise in the number of patients suffering from pollen-based allergies and more precisely hay fever drives the growth of the market. Moreover, the growing number of patients especially children is another contributor to escalating the global pollen allergy market. Rapid urbanization in the advancing countries is the major factor that boosts the growth of the pollen allergies market in the forecast period.

Allergy is considered a risk factor for asthma, chronic inflammatory conditions and reduce quality of life. Because of these factors, there is a high need for the treatment of allergies. The global pollen allergy market is expected to show tremendous growth due to increased Pharmaceutical Research and Development spending and biotechnology investment.

The increase in greenhouse gas can result in pollen-induced reparative disease which is further estimated to cushion the growth of the pollen allergies market. Increasing environmental pollution will further provide opportunities for the growth of the pollen allergies market in the coming years.

Increase in Healthcare Spending and Government Initiatives to Drive the Market Growth

Over the past few decades, it has been noted that global per capita healthcare spending has increased considerably owing to the increasing rate of awareness regarding the availability of myriad treatments and diagnostic methods for treating various diseases.

Increasing healthcare spending is likely to result in increasing demand for better quality and rapid diagnostic methods, and in turn, create high growth opportunities for players operating in the treatment of pollen allergies market.

Respiratory disease places a huge burden on society in terms of disability and premature mortality, and also in direct health service costs, drugs prescribed, and the indirect costs related to lost production. Pollen allergy is frequently accompanied by allergic asthma treatment. This condition is also impacting the global pollen allergy market.

In order to increase awareness about allergic rhinitis, several government organizations have started awareness programs. For instance, Allergy UK is the operational name of the British Allergy Foundation that observes allergy awareness week from April 25 to May 1.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors Are Restraining the Growth in the Pollen Allergy Market?

Increased Awareness Regarding Allergy Immunotherapy to Hamper the Market Growth

Despite a positive growth trajectory, the global pollen allergy market is facing various challenges that are likely to pose a threat to its growth during the forecast period.

The lack of a permanent cure for grass pollen allergy disease and home-based diagnosis are a few restraints to the growth of the global pollen allergy market. The rise in the preference towards the utilization of biosimilars is further projected to impede the growth of the pollen allergies market in the forecast period.

However, the decrease in the awareness of allergy immunotherapy (AIT) amongst patients might further challenge the growth of the pollen allergies market in the near future

Country-Wise Insights

What Makes the US an Attractive Market for Pollen Allergy?

“Increasing Rate of Allergic Diseases in the US to Propel the Market Growth”

The US is estimated to account for over 40% of the North American market in 2023. North America has dominated the global pollen allergy market due to the increased incidence rate of allergies and awareness of therapy.

A study conducted by the American College of Allergy, Asthma & Immunology in 2010 reported that about 16.9 million adults and 6.7 million children were diagnosed with hay fever and its prevalence is increasing by approximately 30% in adults and 40% in children.

The United States Food and Drug Administration 2014 estimated around 30 million people in the United States and 500 million globally suffer from one or other form of hay fever symptoms.

Moreover, the increasing focus on Research and Development to develop novel products to cater to high unmet medical needs is highly impacting the market’s growth.

For instance, GlaxoSmithKline plc announced that the US Food and Drug Administration (FDA) has approved Flonase® Allergy Relief (fluticasone propionate 50 mcg spray), containing the No. 1 prescribed allergy treatment ingredient1, as an over-the-counter (OTC) treatment for temporary relief of the symptoms of hay fever or upper respiratory allergies.2

Why is the Pollen Allergy Market in Europe Expected to Be Highly Opportunistic?

Rising Prevalence of Respiratory Allergic Disorders Driving Growth in the Europe Market

The Europe pollen allergy market is expected to rise at a CAGR of 4.0% from 2023 to 2033. Europe is expected to have the second-largest market for global pollen allergy market. Increasing awareness among people about diseases is also a major factor that may boost the growth of the market in this region.

Europe dominates the pollen allergies market due to the rise in the prevalence of respiratory allergic disorders. Europe is the fastest-growing market in pollen allergy due to increasing healthcare funding by the government. Moreover, an increase in the need for therapeutics is further anticipated to propel the growth pollen allergies market in the region in the coming years.

The Charity Allergy UK estimated that about 18 million people were found to be affected with grass pollen allergy which is more common among children and teenagers. Symptoms of pollen include frequent sneezing, running or blocked nose, and itchy eyes, and throat. In some instances, it can also lead to loss of senses to smell, facial pain, sweating, and severe headache. People suffering from asthma face even worse symptoms which include tight chest, shortness of breath, coughing, and wheezing.

Which Factors Are Supporting Growth of the Pollen Allergy Market in Asia Pacific?

Advancement in Healthcare to Propel the Market Growth

Asia Pacific is anticipated to expand at the fastest CAGR of 3.8% during the forecast period. Asia Pacific emerged as the fastest-growing region in the pollen allergy market owing to the presence of unmet healthcare infrastructure needs and the increasing prevalence of allergic diseases.

Furthermore, favorable government initiatives in regions like Japan and Australia pertaining to drug price adjustment and the development of novel drugs for the treatment of pollen allergy are expected to provide manufacturers with lucrative future growth opportunities.

Country-wise Forecast CAGRs for the Pollen Allergy Market

Country CAGR
The UK 4.0%
India 3.7%
South Korea 3.6%
China 3.8%
The US 4.2%

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category wise Insights

Based on the therapeutic drug class, Which Is the Most Prominent Segment in The Pollen Allergy Market?

Corticosteroids Segment Remains Dominant Among Other Types

Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy are the key segments analyzed in the scope of the study.

Corticosteroids dominated the pollen allergy market in 2023 with a revenue share of 35.5%. Corticosteroids are mostly used as the first line of treatment and are also expected to contribute towards the aforementioned conclusion.

Whereas, calcineurin inhibitors are expected to grow at the fastest CAGR during the forecast period owing to their high response rate and the presence of a strong pipeline of calcineurin inhibitors and semi-synthetic analogs of these inhibitors.

By allergen Type, Which Segment Generates High Revenue in Pollen Allergy Market?

Inhaled Allergen SignificantlyDominated the Market

Based on allergen type, the market is categorized into food, inhaled, drug, and others. Inhaled allergens led the global pollen allergy market in 2023 due to increased incidences of respiratory allergies across the globe. The segment is projected to expand further at the fastest CAGR owing to the high demand for allergy testing and the introduction of specific allergens for the detection of pollen allergy.

The drug allergies segment is also expected to register a strong CAGR of 3.8% from 2023 to 2033. Food allergies were the second-largest segment, in terms of revenue share, and are projected to continue the trend throughout the forecast years. Children are more susceptible to these types of allergic diseases. According to the estimates published by the US National Institute of Health (NIH), the prevalence of food allergies among children is double that of adults.

Start-up Scenario

How do New Entrants Contribute to the Pollen Allergy Market?

With technological innovations happening at a rapid pace, and companies looking for ways to increase customer engagement, start-ups are taking all possible steps to establish a name for themselves in the pollen allergy market.

Some of the start-ups in the pollen allergy market include-

  • Allergie is a provider of an app for allergy detection. It provides an Allergohelp app that helps users to reduce allergic symptoms to avoid allergy triggers. The app offers pollen count or pollen flight forecast data along with pollen types. It also provides a symptom tracker that helps to document symptoms anytime and anywhere and collect information for diagnosis or treatment.
  • Pollen Sense- the world’s only automated sensor network providing live pollen and mold counts!
  • Smart Pollen Monitoring provides an app to manage pollen allergies for patients. The company offers a 3D-based application platform that helps in simulating the pollen in the environment and gives predictive insights for the users. The platform also features the routing ability to track directions without any harmful pollen stimulants and tree blooming statistical data to predict the growth and quantity of pollen in the air.

Competitive Landscape

The professional survey study carefully analyses the operations and overview of the corporate structures and functioning of the leading and major manufacturers and players functional within the global pollen allergy market. It assesses its product offerings, financial outlook, sales, revenue, and growth over the forecast period.

Some of the leading manufacturers and players assessed in the global pollen allergy market are bioMerieux SA, HOB Biotech Group Corp Ltd, Alcon, HYCOR Biomedical, Inc, Immunomic Therapeutics, Quest Diagnostics Incorporated, Omega Diagnostics Group PLC, Siemens Healthcare Private Limited, Stallergenes Greer, Lincoln Diagnostics, Inc., and others

Manufacturers and players functional in the pollen allergy market are adopting various corporate growth strategies such as new product launches, mergers and acquisitions, and geographical expansion, among others.

  • In January 2022, Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy (AIT), announced that the company has entered into a research collaboration on the discovery of biomarkers of AIT efficacy with Imperial College London, a global top ten university with a world-class reputation in science, engineering, business, and medicine.
  • BioMérieux and NecstGen collaborated to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality and safety testing technologies that will allow safe and effective advanced therapeutics production.
  • Astellas Pharma Inc. and Immunomic Therapeutics, Inc. announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the drug candidate ASP0892 for the mitigation of severe hypersensitivity reactions due to peanut allergy. ASP0892 is a new DNA vaccine program based on the investigational LAMP-Vax platform. A Phase I clinical trial to evaluate the safety, tolerability, and immune response of ASP0892 in adults allergic to peanuts has been initiated.

Report Scope

Report Attribute Details
Growth Rate CAGR from 2023 to 2033
Expected Market Value (2023) US$ 5850.8 Million
ProjectedForecast Value (2033) US$ 8828.6 Million
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in USD Million & CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive L&scape, Growth Factors, Trends & Pricing Analysis
Segments Covered
  • Product Type
  • Allergen Type
  • Therapeutics Drug Class
  • End-User
  • Regions
Regions Covered
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)
Key Countries Profiled
  • The US
  • Canada
  • Brazil
  • Mexico
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • India
  • Malaysia
  • Singapore
  • Thailand
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC
  • South Africa
  • Israel
Key Companies Profiled
  • bioMerieux SA
  • HOB Biotech Group Corp Ltd
  • Alcon
  • HYCOR Biomedical, Inc
  • Immunomic Therapeutics
  • Quest Diagnostics Incorporated
  • Omega Diagnostics Group PLC
  • Siemens Healthcare Private Limited
  • Stallergenes Greer
  • Lincoln Diagnostics, Inc.
Customization Available Upon Request

Key Segments Covered in the Pollen Allergy Industry Survey

Pollen Allergy Market by Product Type:

  • Instruments
  • Consumables
  • Services

Pollen Allergy Market by Allergen Type:

  • Food
  • Inhaled
  • Drug
  • Other

Pollen Allergy Market by Therapeutics Drug class:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Auto injectable Epinephrine
  • Immunotherapy

Pollen Allergy Market by End-User:

  • Diagnostic Laboratories
  • Hospitals

Pollen Allergy Market by Region:

  • North America Pollen Allergy Market
  • Latin America Pollen Allergy Market
  • Europe Pollen Allergy Market
  • South Asia Pollen Allergy Market
  • East Asia Pollen Allergy Market
  • Oceania Pollen Allergy Market
  • MEA Pollen Allergy Market

Frequently Asked Questions

What is the expected valuation of the pollen allergy market?

The global pollen allergy market is likely to reach a valuation of US$ 5850.8 million by the end of 2023.

Who are the key players in pollen allergy market?

bioMerieux SA, HOB Biotech Group Corp Ltd, Alcon, HYCOR Biomedical, Inc, and Immunomic Therapeutics are some of the key players in the global pollen allergy market.

What are the future prospects for pollen allergy market sales?

Sales of the pollen allergy market are likely to expand at 4.2% CAGR through 2033.

Which are the top 5 countries driving demand for pollen allergy?

The US, Canada, Japan, China, & Germany are expected to drive most of the demand for the pollen allergy market.

What will be the global pollen allergy market revenue total by 2033?

By the end of 2033, the global market for pollen allergy market is predicted to reach a valuation of US$ 8828.6 Million

Table of Content

1. Executive Summary | Pollen Allergy Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Instruments

        5.3.2. Consumables

        5.3.3. Services

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Allergen Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Allergen Type, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Allergen Type, 2023 to 2033

        6.3.1. Food

        6.3.2. Inhaled

        6.3.3. Drug

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Allergen Type, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Allergen Type, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapeutics Drug Class 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Therapeutics Drug Class, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapeutics Drug Class, 2023 to 2033

        7.3.1. Antihistamines

        7.3.2. Decongestants

        7.3.3. Corticosteroids

        7.3.4. Mast Cell Stabilizers

        7.3.5. Leukotriene Inhibitors

        7.3.6. Nasal Anticholinergics

        7.3.7. Immunomodulators

        7.3.8. Auto injectable Epinephrine

        7.3.9. Immunotherapy

    7.4. Y-o-Y Growth Trend Analysis By Therapeutics Drug Class, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Therapeutics Drug Class, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Diagnostic Laboratories

        8.3.2. Hospitals

        8.3.3. Academic Research Institutes

    8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. South Asia

        9.3.5. East Asia

        9.3.6. Oceania

        9.3.7. Middle East & Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. The US

            10.2.1.2. Canada

        10.2.2. By Product

        10.2.3. By Allergen Type

        10.2.4. By Therapeutics Drug Class 

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Allergen Type

        10.3.4. By Therapeutics Drug Class 

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Product

        11.2.3. By Allergen Type

        11.2.4. By Therapeutics Drug Class 

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Allergen Type

        11.3.4. By Therapeutics Drug Class 

        11.3.5. By End User

    11.4. Key Takeaways

12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. The UK

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Product

        12.2.3. By Allergen Type

        12.2.4. By Therapeutics Drug Class 

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Allergen Type

        12.3.4. By Therapeutics Drug Class 

        12.3.5. By End User

    12.4. Key Takeaways

13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Malaysia

            13.2.1.3. Singapore

            13.2.1.4. Thailand

            13.2.1.5. Rest of South Asia

        13.2.2. By Product

        13.2.3. By Allergen Type

        13.2.4. By Therapeutics Drug Class 

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Allergen Type

        13.3.4. By Therapeutics Drug Class 

        13.3.5. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product

        14.2.3. By Allergen Type

        14.2.4. By Therapeutics Drug Class 

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Allergen Type

        14.3.4. By Therapeutics Drug Class 

        14.3.5. By End User

    14.4. Key Takeaways

15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. Australia

            15.2.1.2. New Zealand

        15.2.2. By Product

        15.2.3. By Allergen Type

        15.2.4. By Therapeutics Drug Class 

        15.2.5. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Allergen Type

        15.3.4. By Therapeutics Drug Class 

        15.3.5. By End User

    15.4. Key Takeaways

16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Product

        16.2.3. By Allergen Type

        16.2.4. By Therapeutics Drug Class 

        16.2.5. By End User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Product

        16.3.3. By Allergen Type

        16.3.4. By Therapeutics Drug Class 

        16.3.5. By End User

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. The US.

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Product

            17.1.2.2. By Allergen Type

            17.1.2.3. By Therapeutics Drug Class 

            17.1.2.4. By End User

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Product

            17.2.2.2. By Allergen Type

            17.2.2.3. By Therapeutics Drug Class 

            17.2.2.4. By End User

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Product

            17.3.2.2. By Allergen Type

            17.3.2.3. By Therapeutics Drug Class 

            17.3.2.4. By End User

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Product

            17.4.2.2. By Allergen Type

            17.4.2.3. By Therapeutics Drug Class 

            17.4.2.4. By End User

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Product

            17.5.2.2. By Allergen Type

            17.5.2.3. By Therapeutics Drug Class 

            17.5.2.4. By End User

    17.6. The UK

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Product

            17.6.2.2. By Allergen Type

            17.6.2.3. By Therapeutics Drug Class 

            17.6.2.4. By End User

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Product

            17.7.2.2. By Allergen Type

            17.7.2.3. By Therapeutics Drug Class 

            17.7.2.4. By End User

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Product

            17.8.2.2. By Allergen Type

            17.8.2.3. By Therapeutics Drug Class 

            17.8.2.4. By End User

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Product

            17.9.2.2. By Allergen Type

            17.9.2.3. By Therapeutics Drug Class 

            17.9.2.4. By End User

    17.10. India

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Product

            17.10.2.2. By Allergen Type

            17.10.2.3. By Therapeutics Drug Class 

            17.10.2.4. By End User

    17.11. Malaysia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Product

            17.11.2.2. By Allergen Type

            17.11.2.3. By Therapeutics Drug Class 

            17.11.2.4. By End User

    17.12. Singapore

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Product

            17.12.2.2. By Allergen Type

            17.12.2.3. By Therapeutics Drug Class 

            17.12.2.4. By End User

    17.13. Thailand

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Product

            17.13.2.2. By Allergen Type

            17.13.2.3. By Therapeutics Drug Class 

            17.13.2.4. By End User

    17.14. China

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Product

            17.14.2.2. By Allergen Type

            17.14.2.3. By Therapeutics Drug Class 

            17.14.2.4. By End User

    17.15. Japan

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Product

            17.15.2.2. By Allergen Type

            17.15.2.3. By Therapeutics Drug Class 

            17.15.2.4. By End User

    17.16. South Korea

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Product

            17.16.2.2. By Allergen Type

            17.16.2.3. By Therapeutics Drug Class 

            17.16.2.4. By End User

    17.17. Australia

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Product

            17.17.2.2. By Allergen Type

            17.17.2.3. By Therapeutics Drug Class 

            17.17.2.4. By End User

    17.18. New Zealand

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Product

            17.18.2.2. By Allergen Type

            17.18.2.3. By Therapeutics Drug Class 

            17.18.2.4. By End User

    17.19. GCC Countries

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Product

            17.19.2.2. By Allergen Type

            17.19.2.3. By Therapeutics Drug Class 

            17.19.2.4. By End User

    17.20. South Africa

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Product

            17.20.2.2. By Allergen Type

            17.20.2.3. By Therapeutics Drug Class 

            17.20.2.4. By End User

    17.21. Israel

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Product

            17.21.2.2. By Allergen Type

            17.21.2.3. By Therapeutics Drug Class 

            17.21.2.4. By End User

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Product

        18.3.3. By Allergen Type

        18.3.4. By Therapeutics Drug Class 

        18.3.5. By End User

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. bioMerieux SA

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. HOB Biotech Group Corp Ltd

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Alcon

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. HYCOR Biomedical, Inc.

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. Immunomic Therapeutics

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. Quest Diagnostics Incorporated

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. Omega Diagnostics Group PLC

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. Siemens Healthcare Private Limited

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Stallergenes Greer

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. Lincoln Diagnostics, Inc.

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

IgE Allergy Blood Tests Market

Published : January 2023

Healthcare

Food Allergy Market

Published : December 2022

Healthcare

Allergy Treatment Market

Published : November 2022

Explore Healthcare Insights

View Reports